226 related articles for article (PubMed ID: 19262752)
1. A functional and regulatory network associated with PIP expression in human breast cancer.
Debily MA; Marhomy SE; Boulanger V; Eveno E; Mariage-Samson R; Camarca A; Auffray C; Piatier-Tonneau D; Imbeaud S
PLoS One; 2009; 4(3):e4696. PubMed ID: 19262752
[TBL] [Abstract][Full Text] [Related]
2. Prolactin-induced protein is required for cell cycle progression in breast cancer.
Naderi A; Vanneste M
Neoplasia; 2014 Apr; 16(4):329-42.e1-14. PubMed ID: 24862759
[TBL] [Abstract][Full Text] [Related]
3. Synergistic action of prolactin (PRL) and androgen on PRL-inducible protein gene expression in human breast cancer cells: a unique model for functional cooperation between signal transducer and activator of transcription-5 and androgen receptor.
Carsol JL; Gingras S; Simard J
Mol Endocrinol; 2002 Jul; 16(7):1696-710. PubMed ID: 12089361
[TBL] [Abstract][Full Text] [Related]
4. Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T-47D.
Murphy LC; Tsuyuki D; Myal Y; Shiu RP
J Biol Chem; 1987 Nov; 262(31):15236-41. PubMed ID: 3667631
[TBL] [Abstract][Full Text] [Related]
5. Prolactin-induced protein (PIP) increases the sensitivity of breast cancer cells to drug-induced apoptosis.
Urbaniak A; Jablonska K; Suchanski J; Partynska A; Szymczak-Kulus K; Matkowski R; Maciejczyk A; Ugorski M; Dziegiel P
Sci Rep; 2023 Apr; 13(1):6574. PubMed ID: 37085653
[TBL] [Abstract][Full Text] [Related]
6. The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis.
Clark JW; Snell L; Shiu RP; Orr FW; Maitre N; Vary CP; Cole DJ; Watson PH
Br J Cancer; 1999 Nov; 81(6):1002-8. PubMed ID: 10576657
[TBL] [Abstract][Full Text] [Related]
7. Tissue-specific androgen-inhibited gene expression of a submaxillary gland protein, a rodent homolog of the human prolactin-inducible protein/GCDFP-15 gene.
Myal Y; Iwasiow B; Yarmill A; Harrison E; Paterson JA; Shiu RP
Endocrinology; 1994 Oct; 135(4):1605-10. PubMed ID: 7925123
[TBL] [Abstract][Full Text] [Related]
8. Estradiol-independent modulation of breast cancer transcript profile by 17beta-hydroxysteroid dehydrogenase type 1.
Aka JA; Calvo EL; Lin SX
Mol Cell Endocrinol; 2017 Jan; 439():175-186. PubMed ID: 27544780
[TBL] [Abstract][Full Text] [Related]
9. Prolactin-Induced Protein regulates cell adhesion in breast cancer.
Vanneste M; Naderi A
Biochem Biophys Res Commun; 2015 Dec; 468(4):850-6. PubMed ID: 26585492
[TBL] [Abstract][Full Text] [Related]
10. Analysis of the miRNA-mRNA-lncRNA networks in ER+ and ER- breast cancer cell lines.
Wu Q; Guo L; Jiang F; Li L; Li Z; Chen F
J Cell Mol Med; 2015 Dec; 19(12):2874-87. PubMed ID: 26416600
[TBL] [Abstract][Full Text] [Related]
11. Expression of the prolactin-inducible protein (PIP/GCDFP15) gene in benign epithelium and adenocarcinoma of the prostate.
Tian W; Osawa M; Horiuchi H; Tomita Y
Cancer Sci; 2004 Jun; 95(6):491-5. PubMed ID: 15182429
[TBL] [Abstract][Full Text] [Related]
12. Meta-analysis based gene expression profiling reveals functional genes in ovarian cancer.
Zhao L; Li Y; Zhang Z; Zou J; Li J; Wei R; Guo Q; Zhu X; Chu C; Fu X; Yue J; Li X
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33135729
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-induced protein in breast cancer.
Naderi A
Adv Exp Med Biol; 2015; 846():189-200. PubMed ID: 25472539
[TBL] [Abstract][Full Text] [Related]
14. Additive effect of the AZGP1, PIP, S100A8 and UBE2C molecular biomarkers improves outcome prediction in breast carcinoma.
Parris TZ; Kovács A; Aziz L; Hajizadeh S; Nemes S; Semaan M; Forssell-Aronsson E; Karlsson P; Helou K
Int J Cancer; 2014 Apr; 134(7):1617-29. PubMed ID: 24114735
[TBL] [Abstract][Full Text] [Related]
15. Prolactin-Inducible Protein: From Breast Cancer Biomarker to Immune Modulator-Novel Insights from Knockout Mice.
Ihedioha OC; Shiu RP; Uzonna JE; Myal Y
DNA Cell Biol; 2016 Oct; 35(10):537-541. PubMed ID: 27602994
[TBL] [Abstract][Full Text] [Related]
16. Association of prolactin-induced protein with preputial development of hypospadias.
Kurokawa S; Kojima Y; Mizuno K; Kamisawa H; Tozawa K; Kohri K; Hayashi Y
BJU Int; 2012 Mar; 109(6):926-32. PubMed ID: 21883842
[TBL] [Abstract][Full Text] [Related]
17. The prolactin-inducible protein (PIP/GCDFP-15) gene: cloning, structure and regulation.
Myal Y; Robinson DB; Iwasiow B; Tsuyuki D; Wong P; Shiu RP
Mol Cell Endocrinol; 1991 Sep; 80(1-3):165-75. PubMed ID: 1955075
[TBL] [Abstract][Full Text] [Related]
18. Prolactin inhibits BCL6 expression in breast cancer through a Stat5a-dependent mechanism.
Tran TH; Utama FE; Lin J; Yang N; Sjolund AB; Ryder A; Johnson KJ; Neilson LM; Liu C; Brill KL; Rosenberg AL; Witkiewicz AK; Rui H
Cancer Res; 2010 Feb; 70(4):1711-21. PubMed ID: 20124477
[TBL] [Abstract][Full Text] [Related]
19. Heat shock protein-90-alpha, a prolactin-STAT5 target gene identified in breast cancer cells, is involved in apoptosis regulation.
Perotti C; Liu R; Parusel CT; Böcher N; Schultz J; Bork P; Pfitzner E; Groner B; Shemanko CS
Breast Cancer Res; 2008; 10(6):R94. PubMed ID: 19014541
[TBL] [Abstract][Full Text] [Related]
20. PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast.
Pagani A; Sapino A; Eusebi V; Bergnolo P; Bussolati G
Virchows Arch; 1994; 425(5):459-65. PubMed ID: 7850069
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]